While obstacles may persist with limited access for patients and researchers, technology can help with this cancer clinical trial paradox.
David M. Kronfeld
Advertisement
Articles by David M. Kronfeld
David M. Kronfeld, the Head of Real World Data Innovation for Medidata, writes of Mercy Hospital in Joplin, Missouri, that despite seeing over 600 new cancer patients each year, it has historically had very limited access to clinical trials
Advertisement
Latest Updated Articles
- The Cancer Trial Paradox – Too Few Patients to Some, Too Few Trials to Others
Published: June 6th 2019 | Updated:
The Cancer Trial Paradox: Too Few Patients to Some, Too Few Trials to OthersPublished: July 1st 2019 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
MATTERHORN Trial Findings Signal Paradigm Shift in Early Gastric Cancer Care
2
Reducing Site Burden Through Better Technology Integration in Clinical Trials
3
ACT Brief: AstraZeneca Expands Immunotherapy Reach as Thermo Fisher’s $8.8B Deal Signals New Phase for Digital Trials
4
ACT Brief: AI, Equity, and Innovation Drive Clinical Research Forward
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
